162 related articles for article (PubMed ID: 9814499)
1. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
Joba W; Spitzweg C; Schriever K; Heufelder AE
Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.
Jhiang SM; Cho JY; Ryu KY; DeYoung BR; Smanik PA; McGaughy VR; Fischer AH; Mazzaferri EL
Endocrinology; 1998 Oct; 139(10):4416-9. PubMed ID: 9751526
[TBL] [Abstract][Full Text] [Related]
4. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical studies of Na+/I- symporter in human thyroid tissues--a correlation with clinical thyroid scintigraphy.
Lee CH; Yang AH; Chang JY; Huang CL; Chi CW
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):141-6. PubMed ID: 11458618
[TBL] [Abstract][Full Text] [Related]
6. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
7. Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
Lin JD; Hsueh C; Chao TC; Weng HF
Endocr Pathol; 2001; 12(1):15-21. PubMed ID: 11478264
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands.
Spitzweg C; Joba W; Schriever K; Goellner JR; Morris JC; Heufelder AE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4178-84. PubMed ID: 10566669
[TBL] [Abstract][Full Text] [Related]
10. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
12. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells.
Castro MR; Bergert ER; Beito TG; McIver B; Goellner JR; Morris JC
J Clin Endocrinol Metab; 1999 Aug; 84(8):2957-62. PubMed ID: 10443704
[TBL] [Abstract][Full Text] [Related]
13. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.
Liou MJ; Lin JD; Chan EC; Liu FH; Chao TC; Weng HF
Cancer Lett; 2000 Nov; 160(1):75-80. PubMed ID: 11098087
[TBL] [Abstract][Full Text] [Related]
14. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of Na+/I- symporter distribution in human extra-thyroidal tissues.
Vayre L; Sabourin JC; Caillou B; Ducreux M; Schlumberger M; Bidart JM
Eur J Endocrinol; 1999 Oct; 141(4):382-6. PubMed ID: 10526253
[TBL] [Abstract][Full Text] [Related]
16. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues.
Lin JD; Chan EC; Chao TC; Chen KT; Hsueh C; Ho YS; Weng HF
Ann Oncol; 2000 May; 11(5):625-9. PubMed ID: 10907960
[TBL] [Abstract][Full Text] [Related]
17. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
18. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.
Smanik PA; Ryu KY; Theil KS; Mazzaferri EL; Jhiang SM
Endocrinology; 1997 Aug; 138(8):3555-8. PubMed ID: 9231811
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein.
Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S
J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985
[TBL] [Abstract][Full Text] [Related]
20. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
